SIX Swiss Exchange · Healthcare
Invest in COLTENE stock from India
Indian and foreign residents can buy COLTENE (CLTN) shares directly through Paasa.
By Paasa · Updated
COLTENE at a glance
- Price
- CHF 46.80-CHF 0.60 (1.27%)
- Market cap
- CHF 279.65M
- Day range
- CHF 46.40 – CHF 47.70
- P/E
- 18.95
- Dividend yield
- 4.27%
- Volume
- 900.00
- 1 month
- -0.21%
- 6 months
- -8.06%
- YTD
- -12.85%
- 1 year
- +2.74%
- 5 years
- -56.51%
COLTENE statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 240.0M | CHF 250.2M | CHF 242.7M | CHF 267.1M | CHF 279.2M |
| Gross profit | CHF 61.5M | CHF 157.0M | CHF 59.7M | CHF 168.4M | CHF 177.1M |
| Operating income | CHF 20.5M | CHF 26.8M | CHF 19.6M | CHF 34.9M | CHF 43.8M |
| Net income | CHF 14.9M | CHF 20.5M | CHF 11.9M | CHF 26.0M | CHF 31.7M |
| Earnings per share | CHF 2.50 | CHF 3.42 | CHF 2.00 | CHF 4.35 | CHF 5.31 |
| EBITDA | CHF 27.7M | CHF 34.2M | CHF 23.8M | CHF 39.9M | CHF 48.1M |
| Total assets | CHF 184.8M | CHF 186.9M | CHF 175.4M | CHF 190.6M | CHF 186.7M |
| Total debt | CHF 47.0M | CHF 40.0M | CHF 45.0M | CHF 47.1M | CHF 42.9M |
| Cash and short-term investments | CHF 20.7M | CHF 21.9M | CHF 18.4M | CHF 24.2M | CHF 25.7M |
| Shareholders' equity | CHF 100.5M | CHF 108.8M | CHF 96.9M | CHF 112.2M | CHF 107.4M |
| Operating cash flow | CHF 13.8M | CHF 28.6M | CHF 26.0M | CHF 23.4M | CHF 32.5M |
| Free cash flow | CHF 9.2M | CHF 22.8M | CHF 17.3M | CHF 15.1M | CHF 22.6M |
| Capital expenditure | −CHF 4.6M | −CHF 5.7M | −CHF 8.7M | −CHF 8.3M | −CHF 9.9M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Basilea Pharmaceutica | BSLN.SW | CHF 65.50 | CHF 810.67M |
| DocMorris | DOCM.SW | CHF 13.32 | CHF 651.20M |
| IVF Hartmann | VBSN.SW | CHF 125.50 | CHF 298.86M |
| Santhera Pharmaceuticals | SANN.SW | CHF 14.28 | CHF 211.79M |
| Ascom | ASCN.SW | CHF 6.03 | CHF 205.99M |
| Newron Pharmaceuticals | NWRN.SW | CHF 7.59 | CHF 157.92M |
| Molecular Partners | MOLN.SW | CHF 3.21 | CHF 120.41M |
| SHL Telemedicine | SHLTN.SW | CHF 1.03 | CHF 38.17M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in COLTENE from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search CLTN and buy
Find COLTENE by name or by its ticker, CLTN, and place your order.
Why invest in COLTENE from India
What COLTENE does
Headquartered in Altstätten, Switzerland, COLTENE Holding AG, established in 2005 and formerly known as Medisize Holding AG until its name change in April 2008, is a global leader in the development, manufacturing, and sale of a diverse range of consumables, instruments, and equipment specifically designed for dentists and dental laboratories. The company's comprehensive product line addresses various aspects of dental care across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. COLTENE operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy COLTENE stock from India?
Yes. Indian residents and NRIs can buy COLTENE (CLTN) shares directly through Paasa. COLTENE is listed on the SIX Swiss Exchange, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell COLTENE shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.